Insider Transactions in Q2 2022 at Amylyx Pharmaceuticals, Inc. (AMLX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 05
2022
|
Joshua B Cohen Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
334,520
+10.35%
|
$0
$0.37 P/Share
|
|
May 05
2022
|
Justin B. Klee Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
334,520
+10.35%
|
$0
$0.37 P/Share
|